Results: 16

Neumonía por Pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn

Fluxá, Daniela; Segovia, Jorge; Florenzano, Matías; Salinas, Jessica; Flores, Lilian; Simian, Daniela; Quera, Rodrigo.

Rev. chil. infectol; 34 (5), 2017

There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn's disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibili...

Enfermedad de Crohn/tratamiento farmacológico, Fármacos Gastrointestinales/efectos adversos, Infliximab/efectos adversos, Neumonía por Pneumocystis/inducido químicamente, Inmunosupresores/efectos adversos, Neumonía por Pneumocystis/diagnóstico por imagen, Radiografía, Factores de Riesgo, Tomografía Computarizada por Rayos X

Fulltext

Lewis-Sumner syndrome associated with infliximab therapy for psoriasis

Oliveira, Karen Fernandes de; Martins, Gladys Aires; Galvão, Keila Rejane Ferreira; Kurizky, Patricia Shu.

An. bras. dermatol; 92 (1), 2017

Enfermedades Desmielinizantes/inducido químicamente, Fármacos Dermatológicos/efectos adversos, Infliximab/efectos adversos, Trastornos Motores/inducido químicamente, Psoriasis/tratamiento farmacológico, Trastornos de la Sensación/inducido químicamente, Síndrome, Linfotoxina-alfa/antagonistas & inhibidores

Fulltext

Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis

Vasconcellos, Jaqueline Barbeito de; Pereira, Daniele do Nascimento; Vargas, Thiago Jeunon de Sousa; Levy, Roger Abramino; Pinheiro, Geraldo da Rocha Castelar; Cursi, Ígor Brum.

An. bras. dermatol; 91 (5,supl.1), 2016

Abstract The use of tumor necrosis factor antagonists (anti-TNF) has become a usual practice to treat various inflammatory diseases. Although indicated for the treatment of psoriasis, anti-TNF may paradoxically trigger a psoriasiform condition. We present a case of a female patient who, during the use of...

Antirreumáticos/efectos adversos, Artritis Reumatoide/tratamiento farmacológico, Infliximab/efectos adversos, Psoriasis/inducido químicamente, Psoriasis/patología, Factor de Necrosis Tumoral alfa/antagonistas & inhibidores, Adalimumab/efectos adversos, Piel/patología

Fulltext

Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients

Antonio, João Roberto; Sanmiguel, Jessica; Cagnon, Giovana Viotto; Augusto, Marília Silveira Faeda; Godoy, Moacir Fernandes de; Pozetti, Eurides Maria Oliveira.

An. bras. dermatol; 91 (3), 2016

Abstract: Background: Psoriasis is immune-mediated chronic inflammatory disease with preference for skin and joints. The skin involvement occurs by hyperproliferation and abnormal differentiation of keratinocytes. It is associated with comorbidities, mainly related to the clinical manifestations of the ...

Antirreumáticos/efectos adversos, Infliximab/efectos adversos, Psoriasis/tratamiento farmacológico, Artritis Reumatoide/tratamiento farmacológico, Enfermedad de Crohn/tratamiento farmacológico, Estudios Transversales, Infliximab/uso terapéutico, Estudios Retrospectivos, Factores Sexuales, Espondilitis Anquilosante/tratamiento farmacológico, Factor de Necrosis Tumoral alfa/antagonistas & inhibidores, Factor de Necrosis Tumoral alfa/metabolismo

Fulltext

Pneumonia por Legionella após uso de Infliximabe em paciente com Artrite Reumatoide

Giassi, Karina de Souza; Junior, Vilson Furlanetto; Fialho, Sonia; Ribeiro, Giovana Gomes; Pereira, Ivânio Alves.

Rev. bras. reumatol; 54 (5), 2014

Os antagonistas do fator de necrose tumoral (anti-TNF) têm sido utilizados com sucesso em várias doenças inflamatórias crônicas, como artrite reumatoide (AR), mas alguns estudos observaram a ocorrência de infecções por patógenos intracelulares em pacientes medicados com anti-TNF. Relatamos um ca...

Antirreumáticos/efectos adversos, Antirreumáticos/uso terapéutico, Artritis Reumatoide/tratamiento farmacológico, Infliximab/efectos adversos, Infliximab/uso terapéutico, Enfermedad de los Legionarios/inducido químicamente, Persona de Mediana Edad, Factor de Necrosis Tumoral alfa/antagonistas & inhibidores

Fulltext

Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience

Kotze, Paulo Gustavo; Akiyoshi, Fernando Kenji; Luvizotto, Mateus; Olandoski, Marcia; Kotze, Lorete Maria da Silva; Coy, Claudio Saddy Rodrigues.

J. coloproctol. (Rio J., Impr.); 33 (1), 2013

INTRODUCTION: Data is scarce regarding adverse events (AE) of biological therapy used in the management of Crohn's Disease (CD) among Brazilian patients. OBJECTIVES: To analyse AE prevalence and profile in patients with CD treated with Infliximab (IFX) or Adalimumab (ADA) and to verify whether there are ...

Enfermedad de Crohn/terapia, Infliximab/efectos adversos, Adalimumab/efectos adversos, Exantema/inducido químicamente, Herpes Zóster/inducido químicamente, Vasculitis Leucocitoclástica Cutánea/inducido químicamente

Fulltext